The board of directors of SSY Group Limited announced that the Group's Lidocaine hydrochloride has obtained the approval for registration from the National Medical Products Administration of China to become a bulk drug for the preparations on the market. Lidocaine hydro chloride is a local anesthesia and antiarrhythmic drug. It is mainly used in infiltration anesthesia, epidural anesthesia, surface anesthesia and nerve conduction block.